Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Cash from Operations (2020 - 2025)

Biofrontera has reported Cash from Operations over the past 6 years, most recently at 2415000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 2415000.0 for Q4 2025, down 137.46% from a year ago — trailing twelve months through Dec 2025 was 13400000.0 (down 30.48% YoY), and the annual figure for FY2025 was 13400000.0, down 30.48%.
  • Cash from Operations for Q4 2025 was 2415000.0 at Biofrontera, up from 3785000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for BFRIW hit a ceiling of 125000.0 in Q2 2022 and a floor of 20990000.0 in Q4 2021.
  • Median Cash from Operations over the past 5 years was 3384000.0 (2021), compared with a mean of 4574250.0.
  • Biggest five-year swings in Cash from Operations: soared 111.83% in 2022 and later plummeted 8360.0% in 2023.
  • Biofrontera's Cash from Operations stood at 20990000.0 in 2021, then skyrocketed by 60.59% to 8272000.0 in 2022, then fell by 7.24% to 8871000.0 in 2023, then surged by 88.54% to 1017000.0 in 2024, then tumbled by 137.46% to 2415000.0 in 2025.
  • The last three reported values for Cash from Operations were 2415000.0 (Q4 2025), 3785000.0 (Q3 2025), and 3100000.0 (Q2 2025) per Business Quant data.